Background: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality
worldwide, with a prevalence of approximately 100 million patients. There is evidence …

Background: An optimal model for telemedicine use in the international care setting has not
been established. Our objective was to describe variables associated with patient outcome …

Introduction Anti-platelet therapy, angiotensin-converting enzyme inhibitors/angiotensin II
receptor blockers, beta-blockers and statins are cost-effective in patients with atherosclerotic …

Background: Less than 1% of the extracorporeal life support organization (ELSO) registry
patients are from South America. Extracorporeal membrane oxygenation (ECMO) is an …

Congenital heart disease (CHD) is a common structural anomaly, affecting ~ 1% of live
births worldwide. Advancements in medical and surgical management have significantly …

Veno-venous extracorporeal membrane oxygenation (ECMO) support surged during the
COVID-19 pandemic. Our program changed the model of care pursuing to protect the …

Background The aims of this study were to identify the main variables associated with intra‐hospital
mortality among patients transferred to a specialized neonatal care center, and to …

Introduction: The prevalence of the population with a history of an occlusive cardiovascular
event has been increasing in recent years, which means that a large number of patients will …

Introduction: Cardiovascular diseases account for over 80% of global deaths. Risk factors
and social determinants influence mortality in patients post acute myocardial infarction (AMI). …

To examine prevalence of verbal, physical, and sexual abuses in young elite athletes, a cross
sectional questionnaire-based survey was conducted during the World Athletics under 20 …